Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingrun Yangmu
- Development stage
- Unknown
- Lead developer
- Shanghai Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
**Qingrun Yangmu** is a traditional Chinese medicine (TCM) formula developed for the treatment of dry eye syndrome and visual fatigue, particularly in patients presenting with Liver-Kidney Yin Deficiency. Originally formulated as an oral liquid hospital preparation by the Hospital of Chengdu University of Traditional Chinese Medicine, it has been co-developed into a Class 1.1 TCM innovative granule formulation (Qingrun Yangmu Granules) by Shanghai Pharmaceuticals Group Traditional Chinese Medicine Research Institute. The herbal composition consists of seven key ingredients: *Dendrobium* (石斛), *Cordyceps cicadae* (金蝉花), *Ophiopogon japonicus* (麦冬), *Adenophora tetraphylla* (南沙参), *Lycium barbarum* (枸杞), *Albizia julibrissin* flower buds (合欢米), and *Buddleja officinalis* (密蒙花). These components work synergistically to nourish Yin, moisten the ocular surface, clear heat, and improve tear film stability. In July 2026, the Chinese National Medical Products Administration (NMPA) approved the clinical trial application (IND) for Qingrun Yangmu Granules to initiate clinical trials for dry eye.
- Other names
- Qingrun Yangmu GranulesQingrun Yangmu KeliQingrun Yangmu KoufuyeQingrun Yangmu Oral Liquid清润养目口服液清润养目颗粒
Beyond the preview
Go deeper on Qingrun Yangmu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qingrun Yangmu.